---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-149336"
form_type: "8-K"
ticker: "ACAD"
cik: "0001070494"
company_name: "ACADIA PHARMACEUTICALS INC"
filed_at: "2024-05-29T23:59:59+00:00"
generated_at: "2026-06-01T07:35:17.449911+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Acadia shareholders elect directors, approve 2024 equity plan at annual meeting

## Summary
- Julian C. Baker, Stephen R. Biggar, and Daniel B. Soland elected as Class II directors.
- 2024 Equity Incentive Plan approved with 131.3M votes for, 9.4M against.
- Say-on-pay advisory vote passed with 132.99M for, 7.64M against.
- Ernst & Young ratified as independent auditor for FY2024 with 150.0M for.

## SEC filing metadata
- accession: 0001193125-24-149336
- form_type: 8-K
- ticker: ACAD
- cik: 0001070494
- company_name: ACADIA PHARMACEUTICALS INC
- filed_at: 2024-05-29T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1070494/000119312524149336/0001193125-24-149336-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1070494/000119312524149336/d27582d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-149336
- JSON: https://secwatch.observer/filing/0001193125-24-149336.json
- Plain text: https://secwatch.observer/filing/0001193125-24-149336.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.